Utsumi Hideo, Yamada Ken-ichi, Ichikawa Kazuhiro, Sakai Kiyoshi, Kinoshita Yuichi, Matsumoto Shingo, Nagai Mika
Department of Bio-Functional Science, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1463-8. doi: 10.1073/pnas.0510670103. Epub 2006 Jan 23.
MRI has provided significant clinical utility in the diagnosis of diseases and will become a powerful tool to assess phenotypic changes in genetically engineered animals. Overhauser enhanced MRI (OMRI), which is a double resonance technique, creates images of free radical distributions in small animals by enhancing the water proton signal intensity by means of the Overhauser effect. Several studies have demonstrated noninvasive assessment of reactive oxygen species generation in small animals by using low frequency electron spin resonance (ESR) spectroscopy/imaging and nitroxyl radicals. In vivo ESR signal intensities of nitroxyl radicals decrease with time after injection; and the decreases are enhanced by reactive oxygen species, generated in oxidative disease models in a site-specific manner. In this study, we show images of nitroxyl radicals with different isotopes by changing the external magnetic field for ESR irradiation between (14)N and (15)N nuclei in field-cycled OMRI. OMRI simultaneously obtained dual images of two individual chemical processes. Oxidation and reduction were monitored in a rate-dependent manner at nanometer scale by labeling membrane-permeable and -impermeable nitroxyl radicals with (14)N and (15)N nuclei. Phantom objects containing ascorbic acid-encapsulated liposomes with membrane-permeable radicals but not membrane-impermeable ones show a time-dependent decrease of the OMRI image intensity. The pharmacokinetics in mice was assessed with OMRI after radical administration. This OMRI technique with dual probes should offer significant applicability to nanometer scale molecular imaging and simultaneous assessment of independent processes in gene-modified animals. Thus, it may become a powerful tool to clarify mechanisms of disease and to monitor pharmaceutical therapy.
磁共振成像(MRI)在疾病诊断中具有重要的临床应用价值,并将成为评估基因工程动物表型变化的有力工具。奥弗豪泽增强磁共振成像(OMRI)是一种双共振技术,通过奥弗豪泽效应增强水质子信号强度,从而生成小动物体内自由基分布的图像。多项研究已证明,利用低频电子自旋共振(ESR)光谱/成像技术和硝酰自由基可对小动物体内活性氧的产生进行无创评估。注射后,硝酰自由基的体内ESR信号强度会随时间降低;在氧化疾病模型中,活性氧以位点特异性方式产生,会增强这种信号强度的降低。在本研究中,我们通过在场循环OMRI中改变用于ESR照射的(14)N和(15)N核的外部磁场,展示了不同同位素的硝酰自由基图像。OMRI同时获得了两个独立化学过程的双重图像。通过用(14)N和(15)N核标记膜通透性和非通透性硝酰自由基,以纳米尺度的速率依赖性方式监测氧化和还原过程。含有抗坏血酸包封脂质体且带有膜通透性自由基而非膜非通透性自由基的模型物体显示,OMRI图像强度随时间下降。自由基给药后,用OMRI评估了小鼠体内的药代动力学。这种具有双探针的OMRI技术应在纳米尺度分子成像以及同时评估基因修饰动物中的独立过程方面具有显著的适用性。因此,它可能成为阐明疾病机制和监测药物治疗的有力工具。